Craniosynostosis (CS) is a relatively prevalent congenital malformation, due to the premature ossification of calvarial sutures that articulate skull bones, leading to a variable alteration of craniofacial landmarks and shape. CS is extremely heterogeneous in both clinical and a etiological aspects. It occurs as an isolated defect (i.e. nonsyndromic) in most cases, while it is syndromic in less than one fourth of cases. A genetic aetiology (i.e. mutations in
FGFR
,
TWIST1
,
EFNB1
,
MSX
, and
ERF
genes, among others) is known for most syndromes. Recent studies helped clarifying the genetic basis of new CS syndromes and nonsyndromic forms. The discovery of new genes (including
RUNX2
,
ALX4
,
TCF12
and
ZIC1
) enabled deciphering the complex signalling network that orchestrates craniofacial development. In this light, the entire CS disease spectrum can be regarded as a nosological continuum, with variable degree of severity, in which a strong genetic component provides the background for environmental factors that contribute to the aetiopathogenesis of the birth defect.
Key Concepts
Craniosynostosis is a frequent congenital defect with a high degree of clinical and genetic heterogeneity.
Nonsyndromic forms are more frequent, although their aetiology is still poorly understood.
Many developmental syndromes include craniosynostosis in their phenotype.
Different closely interacting genes (
FGFR
,
TWIST1
,
MSX2
,
ERF
,
TCF12
, among others) are involved in the molecular genetics of the best characterised and more frequent syndromic craniosynostoses.
Most genes involved in the etiopathogenesis of craniosynostosis interact within a common gene network.